N. R. Labiris

2.1k total citations · 1 hit paper
18 papers, 1.6k citations indexed

About

N. R. Labiris is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Endocrine and Autonomic Systems. According to data from OpenAlex, N. R. Labiris has authored 18 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 6 papers in Physiology and 2 papers in Endocrine and Autonomic Systems. Recurrent topics in N. R. Labiris's work include Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers), Inhalation and Respiratory Drug Delivery (6 papers) and Asthma and respiratory diseases (5 papers). N. R. Labiris is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers), Inhalation and Respiratory Drug Delivery (6 papers) and Asthma and respiratory diseases (5 papers). N. R. Labiris collaborates with scholars based in Canada, Australia and United Kingdom. N. R. Labiris's co-authors include Myrna Dolovich, Anne Holbrook, Martin R. Stämpfli, Stuart MacLeod, Henry Chrystyn, Michael T. Newhouse, Russ Ellis, Mark D. Inman, Mathieu C. Morissette and Troy Farncombe and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and European Respiratory Journal.

In The Last Decade

N. R. Labiris

17 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications

2003 932 citations N. R. Labiris, Myrna Dolovich British Journal of Clinical Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
N. R. Labiris Canada	13	1.3k	360	354	194	177	18	1.6k
Philip J. Kuehl United States	22	906 0.7×	223 0.6×	259 0.7×	185 1.0×	128 0.7×	72	1.4k
Richard N. Dalby United States	25	1.2k 1.0×	356 1.0×	366 1.0×	204 1.1×	146 0.8×	46	1.7k
Glyn Taylor United Kingdom	31	1.1k 0.9×	429 1.2×	356 1.0×	106 0.5×	207 1.2×	109	2.6k
Ralph W. Niven United States	26	1.1k 0.9×	421 1.2×	170 0.5×	191 1.0×	161 0.9×	46	1.7k
Nora Y.K. Chew Australia	21	1.3k 1.1×	473 1.3×	465 1.3×	484 2.5×	189 1.1×	25	1.9k
Cynthia Bosquillon United Kingdom	21	928 0.7×	496 1.4×	184 0.5×	303 1.6×	195 1.1×	41	1.6k
A. Ben-Jebria United States	10	956 0.8×	481 1.3×	160 0.5×	311 1.6×	209 1.2×	18	1.4k
J.N. Pritchard United Kingdom	22	1.3k 1.1×	312 0.9×	385 1.1×	364 1.9×	207 1.2×	53	1.8k
Mary Lou Eskew United States	12	776 0.6×	381 1.1×	126 0.4×	273 1.4×	179 1.0×	25	1.4k
Thomas E. Tarara United States	19	1.0k 0.8×	395 1.1×	199 0.6×	424 2.2×	153 0.9×	31	1.3k

Countries citing papers authored by N. R. Labiris

Since Specialization

Citations

This map shows the geographic impact of N. R. Labiris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. R. Labiris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. R. Labiris more than expected).

Fields of papers citing papers by N. R. Labiris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. R. Labiris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. R. Labiris. The network helps show where N. R. Labiris may publish in the future.

Co-authorship network of co-authors of N. R. Labiris

This figure shows the co-authorship network connecting the top 25 collaborators of N. R. Labiris. A scholar is included among the top collaborators of N. R. Labiris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. R. Labiris. N. R. Labiris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Morissette, Mathieu C., Jake K. Nikota, Pamela Shen, et al.. (2014). Persistence of pulmonary tertiary lymphoid tissues and anti-nuclear antibodies following cessation of cigarette smoke exposure. Respiratory Research. 15(1). 49–49. 40 indexed citations

Morissette, Mathieu C., et al.. (2014). Impact of inflammation, emphysema, and smoking cessation on V/Q in mouse models of lung obstruction. Respiratory Research. 15(1). 42–42. 17 indexed citations

Stämpfli, Martin R., et al.. (2013). Detection of Lung Dysfunction Using Ventilation and Perfusion SPECT in a Mouse Model of Chronic Cigarette Smoke Exposure. Journal of Nuclear Medicine. 54(4). 616–623. 29 indexed citations

Farncombe, Troy, et al.. (2013). Airway and pulmonary vascular measurements using contrast-enhanced micro-CT in rodents. American Journal of Physiology-Lung Cellular and Molecular Physiology. 304(12). L831–L843. 26 indexed citations

Labiris, N. R., et al.. (2012). Imaging Lung Function in Mice Using SPECT/CT and Per-Voxel Analysis. PLoS ONE. 7(8). e42187–e42187. 12 indexed citations

Labiris, N. R., et al.. (2012). Local And Systemic Effects Of Frequent Pulmonary Exacerbations In COPD. A5860–A5860.

Petrik, Jim, et al.. (2011). Fetal and Neonatal Exposure to Nicotine Disrupts Postnatal Lung Development in Rats: Role of VEGF and Its Receptors. International Journal of Toxicology. 30(2). 244–252. 25 indexed citations

Azad, Babak Behnam, et al.. (2011). Temperature effects on the stereospecificity of nucleophilic fluorination: formation of trans‐[¹⁸F]4‐fluoro‐l‐proline during the synthesis of cis‐[¹⁸F]4‐fluoro‐l‐proline. Journal of Labelled Compounds and Radiopharmaceuticals. 55(1). 23–28. 7 indexed citations

Farkas, László, Daniela Farkas, N. R. Labiris, et al.. (2010). VEGF Receptor Inhibition In Experimental Lung Fibrosis Results In Severe Angioproliferative Pulmonary Hypertension And Increased Fibrogenic Activity. A6315–A6315. 1 indexed citations

10.

Ellis, Russ, et al.. (2010). The effects of inhaled house dust mite on airway barrier function and sensitivity to inhaled methacholine in mice. American Journal of Physiology-Lung Cellular and Molecular Physiology. 300(2). L185–L190. 22 indexed citations

11.

Häfeli, Urs O., et al.. (2010). Lung Perfusion Imaging with Monosized Biodegradable Microspheres. Biomacromolecules. 11(3). 561–567. 37 indexed citations

12.

Labiris, N. R., et al.. (2007). The Efficiency of Sputum Cell Counts in Cystic Fibrosis. Canadian Respiratory Journal. 14(2). 99–103. 3 indexed citations

13.

Labiris, N. R., et al.. (2006). Systematic Overview of Drug Interactions with Antidepressant Medications. The Canadian Journal of Psychiatry. 51(5). 300–316. 39 indexed citations

14.

Labiris, N. R. & Myrna Dolovich. (2004). Labiris, N.R. & Dolovich, M.B. Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications. Br. J. Clin. Pharmacol. 56, 588-599. 19 indexed citations

15.

Labiris, N. R., et al.. (2003). Uptake of¹⁸fluorodeoxyglucose in the cystic fibrosis lung: a measure of lung inflammation?. European Respiratory Journal. 21(5). 848–854. 23 indexed citations

16.

Labiris, N. R. & Myrna Dolovich. (2003). Pulmonary drug delivery. Part II: The role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications. British Journal of Clinical Pharmacology. 56(6). 600–612. 324 indexed citations

17.

Labiris, N. R. & Myrna Dolovich. (2003). Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications. British Journal of Clinical Pharmacology. 56(6). 588–599. 932 indexed citations breakdown →

18.

Labiris, N. R., Anne Holbrook, Henry Chrystyn, Stuart MacLeod, & Michael T. Newhouse. (1999). Dry Powder versus Intravenous and Nebulized Gentamicin in Cystic Fibrosis and Bronchiectasis: A Pilot Study. American Journal of Respiratory and Critical Care Medicine. 160(5). 1711–1716. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact